Advertisement

Topics

Too many disappointments from Teva

14:40 EDT 3 Aug 2017 | Globes

Teva's poor results cut short a rally in its share sparked by good clinical results for its migraine headache drug.

Original Article: Too many disappointments from Teva

NEXT ARTICLE

More From BioPortfolio on "Too many disappointments from Teva"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...